JP2008526209A - 高齢期の動物の生活の質を高めるための方法 - Google Patents
高齢期の動物の生活の質を高めるための方法 Download PDFInfo
- Publication number
- JP2008526209A JP2008526209A JP2007549655A JP2007549655A JP2008526209A JP 2008526209 A JP2008526209 A JP 2008526209A JP 2007549655 A JP2007549655 A JP 2007549655A JP 2007549655 A JP2007549655 A JP 2007549655A JP 2008526209 A JP2008526209 A JP 2008526209A
- Authority
- JP
- Japan
- Prior art keywords
- ppm
- animal
- weight
- composition
- quality
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 82
- 238000000034 method Methods 0.000 title claims abstract description 80
- 239000000203 mixture Substances 0.000 claims abstract description 106
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims abstract description 28
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 13
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 13
- 239000011707 mineral Substances 0.000 claims abstract description 13
- 210000000845 cartilage Anatomy 0.000 claims abstract description 11
- 210000003205 muscle Anatomy 0.000 claims abstract description 11
- 230000036626 alertness Effects 0.000 claims abstract description 10
- 241000282472 Canis lupus familiaris Species 0.000 claims description 45
- 239000003925 fat Substances 0.000 claims description 26
- 235000019197 fats Nutrition 0.000 claims description 26
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 23
- 241000282326 Felis catus Species 0.000 claims description 22
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 20
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 18
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 18
- 235000018102 proteins Nutrition 0.000 claims description 18
- 102000004169 proteins and genes Human genes 0.000 claims description 18
- 108090000623 proteins and genes Proteins 0.000 claims description 18
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 18
- 235000015097 nutrients Nutrition 0.000 claims description 14
- 235000006708 antioxidants Nutrition 0.000 claims description 12
- 235000010755 mineral Nutrition 0.000 claims description 12
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 11
- 229940088594 vitamin Drugs 0.000 claims description 11
- 229930003231 vitamin Natural products 0.000 claims description 11
- 235000013343 vitamin Nutrition 0.000 claims description 11
- 239000011782 vitamin Substances 0.000 claims description 11
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- 239000011709 vitamin E Substances 0.000 claims description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 9
- 229930003268 Vitamin C Natural products 0.000 claims description 9
- 239000008107 starch Substances 0.000 claims description 9
- 235000019698 starch Nutrition 0.000 claims description 9
- 229960003080 taurine Drugs 0.000 claims description 9
- 235000019154 vitamin C Nutrition 0.000 claims description 9
- 239000011718 vitamin C Substances 0.000 claims description 9
- 235000021120 animal protein Nutrition 0.000 claims description 8
- 229960001231 choline Drugs 0.000 claims description 8
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 8
- 230000006872 improvement Effects 0.000 claims description 8
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 7
- 108010064851 Plant Proteins Proteins 0.000 claims description 7
- 229960004203 carnitine Drugs 0.000 claims description 7
- 229930182817 methionine Natural products 0.000 claims description 7
- 235000021118 plant-derived protein Nutrition 0.000 claims description 7
- 239000004472 Lysine Substances 0.000 claims description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 6
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims description 6
- 235000019136 lipoic acid Nutrition 0.000 claims description 6
- 229960002663 thioctic acid Drugs 0.000 claims description 6
- 235000019871 vegetable fat Nutrition 0.000 claims description 6
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 4
- 235000018417 cysteine Nutrition 0.000 claims description 4
- 244000144977 poultry Species 0.000 claims description 4
- 241000283086 Equidae Species 0.000 claims description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- 229960003067 cystine Drugs 0.000 claims description 3
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 3
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 2
- 235000013734 beta-carotene Nutrition 0.000 claims description 2
- 239000011648 beta-carotene Substances 0.000 claims description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 2
- 229960002747 betacarotene Drugs 0.000 claims description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 235000019621 digestibility Nutrition 0.000 abstract description 10
- 238000012423 maintenance Methods 0.000 abstract description 9
- 230000002708 enhancing effect Effects 0.000 abstract description 6
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 description 21
- 230000037213 diet Effects 0.000 description 20
- 239000000654 additive Substances 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 8
- 235000013599 spices Nutrition 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 239000013589 supplement Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 241000271566 Aves Species 0.000 description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000021323 fish oil Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000021048 nutrient requirements Nutrition 0.000 description 3
- 235000013594 poultry meat Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- 239000006057 Non-nutritive feed additive Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 230000001149 cognitive effect Effects 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 235000021110 pickles Nutrition 0.000 description 2
- IVDFJHOHABJVEH-UHFFFAOYSA-N pinacol Chemical compound CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000021127 solid diet Nutrition 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282421 Canidae Species 0.000 description 1
- 241000824799 Canis lupus dingo Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 206010007710 Cartilage injury Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000700114 Chinchillidae Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 241001417105 Clupea pallasii Species 0.000 description 1
- 241001454694 Clupeiformes Species 0.000 description 1
- 102000000503 Collagen Type II Human genes 0.000 description 1
- 108010041390 Collagen Type II Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- TYLNXKAVUJJPMU-DNKOKRCQSA-N Docosahexaenoic acid ethyl ester Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(=O)OCC TYLNXKAVUJJPMU-DNKOKRCQSA-N 0.000 description 1
- 239000004344 EU approved packaging gas Substances 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000289659 Erinaceidae Species 0.000 description 1
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 1
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000699694 Gerbillinae Species 0.000 description 1
- 101800001586 Ghrelin Proteins 0.000 description 1
- 102400000442 Ghrelin-28 Human genes 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241000277334 Oncorhynchus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000004067 Osteocalcin Human genes 0.000 description 1
- 108090000573 Osteocalcin Proteins 0.000 description 1
- 241000282579 Pan Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010066207 Poultry Proteins Proteins 0.000 description 1
- 241000287530 Psittaciformes Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
- 235000012377 Salvia columbariae var. columbariae Nutrition 0.000 description 1
- 240000005481 Salvia hispanica Species 0.000 description 1
- 235000001498 Salvia hispanica Nutrition 0.000 description 1
- 241000736062 Scomber scombrus Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000287219 Serinus canaria Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 238000010793 Steam injection (oil industry) Methods 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 241000282458 Ursus sp. Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960001570 ademetionine Drugs 0.000 description 1
- 235000019513 anchovy Nutrition 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000014167 chia Nutrition 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000007882 dietary composition Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- 235000020888 liquid diet Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- -1 luetin Natural products 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 229940068778 tocotrienols Drugs 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K5/00—Feeding devices for stock or game ; Feeding wagons; Feeding stacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biodiversity & Conservation Biology (AREA)
- Birds (AREA)
- Animal Behavior & Ethology (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Feed For Specific Animals (AREA)
Abstract
Description
本出願は、2004年12月30日に出願されたU.S.予備出願シリアルNo.60/640,890に対する優先権を主張し、その開示は、参考とすることによって本明細書に組み込む。
発明の分野
ペット動物、例えば、イヌおよびネコは、それらの成長段階(年齢)、サイズ、体組成および品種に依存して異なる食餌を必要とすることが多い。イヌおよびネコの栄養分要求量とも、年齢に基づき3つの異なるカテゴリー:発育期のイヌ(またはネコ)、熟年期のイヌ(またはネコ)および高齢期のイヌ(またはネコ)に、分類することができる。この最後のカテゴリー、高齢期のイヌ(またはネコ)は、さらに、2つの段階に分類することができ、この2つの段階としては、高齢期(または成熟しきった熟年期)と超高齢期(または老齢期)とが挙げられる。イヌは、さらに、普通の品種のイヌ対大型品種のイヌについての異なるカテゴリーに分類される。
定義
“高齢期(senior)”または“成熟しきった熟年期(mature adult)”という用語は、動物の成長段階を指す。小型または普通の品種のイヌについては、“高齢期”段階は、約7歳〜約10歳である。ネコについては、“高齢期”段階は、約7歳〜約12歳である。大型の品種のイヌについては、5歳を上回る年齢は、以降に記載するように、“超高齢期”と表す。
発明
(a) 0.02%(もしくは約0.5%〜約10%または約0.1%〜約6%)の少なくとも1種のオメガ-3ポリ不飽和脂肪酸;および、
(b) 以下の:
(i) 約10%〜約55%(もしくは約18%〜約30%または約33%〜約55%あるいは約18%〜約20%もしくは約33%〜約36%)の蛋白質;
(ii) 約7%〜約35%(もしくは約18%〜約35%または約7%〜約24%あるいは約14%〜約24%もしくは約14%〜約16%または約18%〜約24%)の脂肪;および、
(iii) 少なくとも約0.05ppm(もしくは約0.05ppm〜約7500ppmまたは約250ppm〜約3600ppmあるいは約250ppm〜約1650ppmもしくは約5ppm〜約225ppmまたは約0.05ppm〜約2.4ppm)の抗酸化剤;
の少なくとも1種;
を含む。
(a) 以下の:
(i) 少なくとも約0.02%(もしくは約0.02%〜約0.3%または約0.05%〜約0.3%あるいは約0.05%〜約0.2%)のDHA;および
(ii) 少なくとも約0.1%(もしくは約0.1%〜約0.5%または約0.2%〜約0.5%あるいは約0.2%〜約0.3%)のEPA;
の少なくとも1種;
(b) 少なくとも約9%(もしくは約9%〜約30%または約18%〜約30%あるいは約18%〜約20%)の蛋白質;
(c) 少なくとも約7%(もしくは約7%〜約24%または約14%〜約24%あるいは約14%〜約16%)の脂肪;および、
(d) 以下の:
(i) 少なくとも約250ppm(もしくは約250ppm〜約1500ppmまたは約500ppm〜約1500ppmあるいは約500ppm〜約1000ppm)のビタミンE;
(iv) 少なくとも約50ppm(もしくは約50ppm〜約500ppmまたは約100ppm〜約500ppmあるいは約100ppm〜約301ppm)のビタミンC;
(v) 少なくとも約600ppm(もしくは約600ppm〜約2400ppmまたは約1260ppm〜約2400ppmあるいは約1260ppm〜約1545ppm)のタウリン;
(vi) 少なくとも約50ppm(もしくは約50ppm〜約200ppmまたは約100ppm〜約160ppmあるいは約100ppm〜約155ppm)のリポ酸;および、
(vii) 少なくとも約150ppm(もしくは約150ppm〜約500ppmまたは約200ppm〜約500ppmあるいは約200ppm〜約350ppm)のカルニチン;
の少なくとも1種;
を含む。
(a) 以下の:
(i) 少なくとも約0.02%((もしくは約0.02%〜約0.3%または約0.05%〜約0.3%あるいは約0.05%〜約0.2%)のDHA;および
(ii) 少なくとも約0.1%(もしくは約0.1%〜約0.5%または約0.2%〜約0.5%あるいは約0.2%〜約0.3%)のEPA;
の少なくとも1種;
(b) 少なくとも約9%(もしくは約9%〜約30%または約18%〜約30%あるいは約18%〜約20%)の蛋白質;
(c) 少なくとも約7%(もしくは約7%〜約24%または約14%〜約24%あるいは約14%〜約16%)の脂肪;および、
(d) 以下の:
(i) 少なくとも約250ppm(もしくは約250ppm〜約1500ppmまたは約500ppm〜約1500ppmあるいは約500ppm〜約1000ppm)のビタミンE;
(viii) 少なくとも約50ppm(もしくは約50ppm〜約500ppmまたは約100ppm〜約500ppmあるいは約100ppm〜約301ppm)のビタミンC;
(ix) 少なくとも約600ppm(もしくは約600ppm〜約2400ppmまたは約1260ppm〜約2400ppmあるいは約1260ppm〜約1575ppm)のタウリン;および、
(x) 少なくとも約50ppm(もしくは約50ppm〜約200ppmまたは約100ppm〜約160ppmあるいは約100ppm〜約155ppm)のリポ酸;および、
(xi) 少なくとも約150ppm(もしくは約150ppm〜約500ppmまたは約200ppm〜約500ppmあるいは約200ppm〜約350ppm)のカルニチン;
の少なくとも1種;
を含む。
(a) 以下の:
(i) 少なくとも約0.05%(もしくは約0.05%〜約0.30%または約0.1%〜約0.3%あるいは約0.1%〜約0.2%)のDHA;および、
(ii) 少なくとも約0.1%(もしくは約0.1%〜約0.5%または約0.2%〜約0.5%あるいは約0.2%〜約0.3%)のEPA;
の少なくとも1種;
(b) 少なくとも約15%(もしくは約15%〜約55%または約30%〜約55%あるいは約33%〜約36%)の蛋白質;
(c) 少なくとも約9%(もしくは約9%〜約35%または約18%〜約35%あるいは約18%〜約24%)の脂肪;および、
(d) 以下の:
(i) 少なくとも約250ppm(もしくは約250ppm〜約1500ppmまたは約500ppm〜約1500ppmあるいは約500ppm〜約1100ppm)のビタミンE;
(xii) 少なくとも約50ppm(もしくは約50ppm〜約300ppmまたは約100ppm〜約300ppmあるいは約100ppm〜約200ppm)のビタミンC;
(xiii) 少なくとも約1100ppm(もしくは約1100ppm〜約3500ppmまたは約2300ppm〜約3500ppmあるいは約2300ppm〜約2350ppm)のタウリン;および、
(xiv) 少なくとも約200ppm(もしくは約200ppm〜約750ppmまたは約400ppm〜約750ppmあるいは約400ppm〜約525ppm)のカルニチン;ならびに、
(xv) 少なくとも約0.05%(もしくは約0.05%〜約6%または約0.1%〜約0.6%あるいは約0.1%〜約0.4%)のシスチン;
の少なくとも1種;
を含む。
(a) 0.02%(もしくは約0.5%〜約10%または約0.1%〜約6%)の少なくとも1種のオメガ-3ポリ不飽和脂肪酸;ならびに、
(b) 以下の:
(xvi) 約10%〜約55%(もしくは約18%〜約30%または約33%〜約55%あるいは約33%〜約55%もしくは約33%〜約36%)の蛋白質;
(xvii) 約7%〜約35%(もしくは約18%〜約35%または約7%〜約24%あるいは約14%〜約24%もしくは約14%〜約16%または約18%〜約24%)の脂肪;
(viii) 少なくとも約0.05(もしくは約0.05ppm〜約7500ppmまたは約250ppm〜約3600ppmまたは約250ppm〜約1650ppmあるいは約5ppm〜約225ppmもしくは約0.05ppm〜約2.4ppm)の抗酸化剤;および、
(xix) 少なくとも約1000ppm(もしくは約1000ppm〜約5000ppmまたは約3300ppm〜約5000ppmあるいは約2000ppm〜約3000ppmもしくは約3000ppm〜約4000ppm)のコリン;
の少なくとも1種;
を含む。
(a) 以下の:
(i) 少なくとも約0.02%((もしくは約0.02%〜約0.3%または約0.05%〜約0.3%あるいは、約0.05%〜約0.2%)のDHA;および、
(ii) 少なくとも約0.1%(もしくは約0.1%〜約0.5%または約0.2%〜約0.5%あるいは約0.2%〜約0.3%)のEPA;
の少なくとも1種;
(b) 少なくとも約9%(もしくは約9%〜約30%または約18%〜約30%あるいは約18%〜約20%)の蛋白質;
(c) 少なくとも約7%(もしくは約7%〜約24%または約14%〜約24%あるいは約14%〜約16%)の脂肪;
(d) 以下の:
(i) 少なくとも約250ppm(もしくは約250ppm〜約1500ppmまたは約500ppm〜約1500ppmあるいは約500ppm〜約1100ppm)のビタミンE;
(xvii) 少なくとも約50ppm(もしくは約50ppm〜約500ppmまたは約100ppm〜約500ppmあるいは約100ppm〜約301ppm)のビタミンC;
(xxi) 少なくとも約600ppm(もしくは約600ppm〜約2400ppmまたは約1260ppm〜約2400ppmあるいは約1260ppm〜約1545ppm)のタウリン;および、
(xxii) 少なくとも約50ppm(もしくは約50ppm〜約200ppmまたは約100ppm〜約160ppmあるいは約100ppm〜約155ppm)のリポ酸;および、
(xxiii) 少なくとも約150ppm(もしくは約150ppm〜約500ppnまたは約200ppm〜約500ppmあるいは約200ppm〜約350ppm)のカルニチン;
の少なくとも1種;
(e) 少なくとも約1000ppm(もしくは約1000ppm〜約3200ppmまたは約2000ppm〜約3200ppmあるいは約2000ppm〜約2500ppm)のコリン;
(f) 少なくとも約50ppm(もしくは約50ppm〜約150ppmまたは約100ppm〜約150ppmあるいは約100ppm〜約110ppm)のマンガン;および、
(g) 少なくとも約0.4%(もしくは約0.4%〜約2%または約0.9%〜約2%あるいは約0.9%〜約1.2%)のリシン;ならびに、
(h) 少なくとも約0.4%〜約1.5%のメチオニン;
を含む。
(a) 以下の:
(i) 少なくとも約0.02%(もしくは約0.02%〜約0.3%または約0.05%〜約0.3%wるいは約0.05%〜約0.2%)のDHA;および、
(ii) 少なくとも約0.1%(もしくは約0.1%〜約0.5%または約0.2%〜約0.5%あるいは約0.2%〜約0.3%)のEPA;
の少なくとも1種;
(b) 少なくとも約9%(もしくは約9%〜約30%または約18%〜約30%あるいは約18%〜約20%)の蛋白質;
(c) 少なくとも約7%(もしくは約7%〜約24%または約14%〜約24%あるいは約14%〜約16%)の脂肪;
(d) 以下の:
(i) 少なくとも約250ppm(もしくは約250ppm〜約1500ppmまたは約500ppm〜約1500ppmあるいは約500ppm〜約1000ppm)のビタミンE;
(xxiv) 少なくとも約50ppm(もしくは約50ppm〜約500ppmまたは約100ppm〜約500ppmあるいは約100ppm〜約301ppm)のビタミンC;
(xxv) 少なくとも約600ppm(もしくは約600ppm〜約2400ppmまたは約1260ppm〜約2400ppmあるいは約1260ppm〜約1545ppm)のタウリン;および、
(xxvi) 少なくとも約50ppm(もしくは約50ppm〜約200ppmまたは約100ppm〜約160ppmあるいは約100ppm〜約155ppm)のリポ酸;ならびに、
(xxvii) 少なくとも約150ppm(もしくは約150ppm〜約500ppmまたは約200ppm〜約500ppmあるいは約200ppm〜約350ppm)のカルニチン
のうちの少なくとも1種;
(e) 少なくとも約1000ppm(もしくは約1000ppm〜約3200ppmまたは約2000ppm〜約3200ppmあるいは約2000ppm〜約25000ppm)のコリン;
(f) 少なくとも約50ppm(もしくは約50ppm〜約150ppmまたは約100ppm〜約150ppmあるいは約100ppm〜約110ppm)のマンガン;および、
(g) 少なくとも約0.4%(もしくは約0.4%〜約2%または約0.9%〜約2%あるいは約0.9%〜約1.2%)のリシン;ならびに、
(h) 少なくとも約0.4%〜約1.5%のメチオニン;
を含む。
その組成物は、概して、
(a) 以下の:
(i) 少なくとも約0.05%((もしくは約0.05%〜約0.30%または約0.1%〜約0.5%あるいは約0.1%〜約0.2%)のDHA;および、
(ii) 少なくとも約0.1%(もしくは約0.1%〜約0.5%または約0.2%〜約0.5%あるいは約0.2%〜約0.3%)のEPA;
の少なくとも1種;
(b) 少なくとも約15%(もしくは約15%〜約55%または約30%〜約55%あるいは約33%〜約36%)の蛋白質;
(c) 少なくとも約9%(もしくは約9%〜約35%または約18%〜約35%あるいは約18%〜約24%)の脂肪;
(d) 以下の:
(i) 少なくとも約250ppm(もしくは約250ppm〜約1500ppmまたは約500ppm〜約1500ppmあるいは約500ppm〜約1100ppm)のビタミンE;
(xxviii) 少なくとも約50ppm(もしくは約50ppm〜約300ppmまたは約100ppm〜約300ppmあるいは約100ppm〜約200ppm)のビタミンC;
(xxix) 少なくとも約1100ppm(もしくは約1100ppm〜約3500ppmまたは約2300ppm〜約3500ppmあるいは約2300ppm〜約2350ppm)のタウリン;および、
(xxx) 少なくとも約200ppm(もしくは約200ppm〜約750ppmまたは約400ppm〜約750ppmあるいは約400ppm〜約525ppm)のカルニチン;ならびに、
(xxxi) 少なくとも約0.05%(もしくは約0.05%〜約0.6%または約0.1%〜約0.6%あるいは約0.1%〜約0.4%)のシスチン;
の少なくとも1種;
(e) 少なくとも約1600ppm(もしくは約1600ppm〜約5000ppmまたは約3300ppm〜約5000ppmあるいは約3300ppm〜約3400ppm)のコリン;
(f) 少なくとも約50ppm(もしくは約50ppm〜約150ppmまたは約100ppm〜約150ppmあるいは約100ppm〜約110ppm)のマンガン;および、
(g) 少なくとも約0.7%(もしくは約0.7%〜約3%または約1.4%〜約3%あるいは約1.4%〜約1.7%)のリシン;ならびに
(h) 少なくとも約0.4%〜約1.5%のメチオニン;
を含む。
約60重量%〜約70重量%の澱粉;
動物蛋白質および植物蛋白質からなる群より選択される約15重量%〜約25重量%の蛋白質;
動物脂肪および植物脂肪からなる群より選択される約5重量%〜約7重量%の脂肪;
約2.5重量%〜約4重量%の少なくとも1種のオメガ-3ポリ3不飽和脂肪酸;
約1重量%〜約2重量%の繊維;
約1重量%〜約2重量%のミネラル類;および、
約0.5重量%〜約1.5重量%のビタミン類;
を含む組成物を食餌させる工程を含む。
約60重量%〜約70重量%の澱粉;
動物蛋白質および植物蛋白質からなる群より選択される約15重量%〜約25重量%の蛋白質;
動物脂肪および植物脂肪からなる群より選択される約5重量%〜約7重量%の脂肪;
約3重量%〜約5重量%の少なくとも1種のポリ-3不飽和脂肪酸;
約1重量%〜約1.5重量%の繊維;
約0.5重量%〜約1重量%のミネラル類;および、
約0.75重量%〜約1.25重量%のビタミン類;
を含む組成物を食餌させる工程を含む。
約30重量%〜約35重量%の澱粉;
動物蛋白質および植物蛋白質からなる群より選択される約40重量%〜約50重量%の蛋白質;
動物脂肪および植物脂肪からなる群より選択される約12重量%〜約15重量%の脂肪;
約1重量%〜約2重量%の少なくとも1種のオメガ-30ポリ不飽和脂肪酸;
約3重量%〜約5重量%の繊維;
約1重量%〜約2重量%のミネラル類;および、
約1重量%〜約2重量%のビタミン類;
を含む組成物を食餌させる工程を含む。
実施例1
Claims (22)
- 高齢期または超高齢期の動物の生活の質を改善するための方法であって、
少なくとも約9重量%の蛋白質;
少なくとも約5重量%の脂肪;および、
少なくとも約0.05重量%の少なくとも1種のオメガ-3ポリ不飽和脂肪酸;
を含む組成物をその動物に食餌させる工程を含む方法。 - その方法が、動物の生活の質を高めるのに有効な量の組成物をその動物に食餌させる工程を含み、生活の質の向上が、警戒心、活力度、軟骨保護、筋肉の塊の維持ならびに皮膚および毛皮の質からなる群より選択される1つ以上の特性における改善によって立証される、請求項1に記載の方法。
- その方法が、警戒心を高めるのに有効な量の組成物をその動物に食餌させる工程を含む、請求項1に記載の方法。
- その方法が、活力度を改善するのに有効な量の組成物をその動物に食餌させる工程を含む、請求項1に記載の方法。
- その方法が、軟骨を保護するのに有効な量の組成物をその動物に食餌させる工程を含む、請求項1に記載の方法。
- その方法が、筋肉の塊を維持するのに有効な量の組成物をその動物に食餌させる工程を含む、請求項1に記載の方法。
- その方法が、皮膚および毛皮の質を改善するのに有効な量の組成物をその動物に食餌させる工程を含む、請求項1に記載の方法。
- 動物が、ネコ、イヌおよびウマからなる群より選択される、請求項1に記載の方法。
- 高齢期または超高齢期の動物の生活の質を改善するための方法であって、
ドコサヘキサエン酸およびエイコサペンタエン酸からなる群より選択される少なくとも1種のオメガ-3ポリ不飽和脂肪酸;
少なくとも1種の抗酸化剤;および、
コリン、マンガン、メチオニン、システイン、L-カルニチン、リシンおよびそれらの混合物からなる群より選択される少なくとも1種の栄養分;
を含む組成物をその動物に食餌させる工程を含む方法。 - 組成物中のオメガ-3ポリ不飽和脂肪酸が、DHAであり、組成物が、乾燥物質基準で測定して、少なくとも約0.02重量%のDHAを含む、請求項9に記載の方法。
- 組成物中のオメガ-3ポリ不飽和脂肪酸が、DHAであり、組成物が、乾燥物質基準で測定して、約0.02重量%〜約0.40重量%のDHAを含む、請求項9に記載の方法。
- 組成物中のオメガ-3ポリ不飽和脂肪酸が、EPAを含み、組成物が、乾燥物質基準で測定して、少なくとも約0.1重量%のEPAを含む、請求項9に記載の方法。
- 組成物中のオメガ-3ポリ不飽和脂肪酸が、EPAを含み、組成物が、乾燥物質基準で測定して、約0.1重量%〜約1重量%のEPAを含む、請求項9に記載の方法。
- 組成物中のオメガ-3ポリ不飽和脂肪酸が、DHAおよびEPAの混合物を含み、組成物が、乾燥物質基準で、少なくとも約0.02重量%のDHAおよび少なくとも約0.1重量%のEPAを含む、請求項9に記載の方法。
- 組成物が、ビタミンE、ビタミンC、タウリン、ベータ-カロテン、カルニチン、リポ酸およびシスチンからなる群より選択される1種以上の抗酸化剤を含む、請求項9に記載の方法。
- 組成物が、少なくとも500ppmのビタミンE、少なくとも約50ppmのビタミンCおよび少なくとも約600ppmのタウリンを含む、請求項9に記載の方法。
- 組成物が、さらに、少なくとも約1000ppmのコリンを含む、請求項9に記載の方法。
- 動物に食餌される組成物が、動物のちそう品または動物のおしゃぶりである、請求項9に記載の方法。
- 組成物が、栄養補給物として動物に食餌される、請求項9に記載の方法。
- 高齢期または超高齢期の小型または普通の品種のイヌの生活の質を改善するための方法であって、
約60重量%〜約70重量%の澱粉;
動物蛋白質および植物蛋白質からなる群より選択される約15重量%〜約25重量%の蛋白質;
動物脂肪および植物脂肪からなる群より選択される約5重量%〜約7重量%の脂肪;
約2.5重量%〜約4重量%の少なくとも1種のオメガ-3ポリ不飽和脂肪酸;
約1重量%〜約2重量%の繊維;
約1重量%〜約2重量%のミネラル類;および、
約0.5重量%〜約1.5重量%のビタミン類;
を含む組成物をその動物に食餌させる工程を含む方法。 - 高齢期または超高齢期の大型品種のイヌの生活の質を改善するための方法であって、
約60重量%〜約70重量%の澱粉;
動物蛋白質および植物蛋白質からなる群より選択される約15重量%〜約25重量%の蛋白質;
動物脂肪および植物脂肪からなる群より選択される約5重量%〜約7重量%の脂肪;
約3重量%〜約5重量%の少なくとも1種のオメガ-3ポリ不飽和脂肪酸;
約1重量%〜約1.5重量%の繊維;
約0.5重量%〜約1重量%のミネラル類;および、
約0.75重量%〜約1.25重量%のビタミン類;
を含む組成物をその動物に食餌させる工程を含む方法。 - 高齢期または超高齢期のネコの生活の質を改善するための方法であって、
約30重量%〜約35重量%の澱粉;
動物蛋白質および植物蛋白質からなる群より選択される約40重量%〜約50重量%の蛋白質;
動物脂肪および植物脂肪からなる群より選択される約12重量%〜約15重量%の脂肪;
約1重量%〜約2重量%の少なくとも1種のオメガ-3ポリ不飽和脂肪酸;
約3重量%〜約5重量%の繊維;
約1重量%〜約2重量%のミネラル類;および、
約1重量%〜約2重量%のビタミン類;
を含む組成物をその動物に食餌させる工程を含む方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64089004P | 2004-12-30 | 2004-12-30 | |
US60/640,890 | 2004-12-30 | ||
PCT/US2005/047461 WO2006074089A2 (en) | 2004-12-30 | 2005-12-30 | Methods for enhancing the quality of life of a senior animal |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008526209A true JP2008526209A (ja) | 2008-07-24 |
JP5295567B2 JP5295567B2 (ja) | 2013-09-18 |
Family
ID=36648067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007549655A Active JP5295567B2 (ja) | 2004-12-30 | 2005-12-30 | 高齢期の動物の生活の質を高めるための方法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US8148325B2 (ja) |
EP (1) | EP1830629A4 (ja) |
JP (1) | JP5295567B2 (ja) |
CN (2) | CN101128109B (ja) |
AU (1) | AU2005322887B2 (ja) |
BR (1) | BRPI0519610A2 (ja) |
CA (2) | CA2592844C (ja) |
RU (1) | RU2367195C2 (ja) |
WO (1) | WO2006074089A2 (ja) |
ZA (1) | ZA200705214B (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011505876A (ja) * | 2007-12-21 | 2011-03-03 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | ペット用飼料組成物 |
JP2012513767A (ja) * | 2008-12-30 | 2012-06-21 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | リポ酸を含むコンパニオンアニマル用組成物およびその使用の方法 |
JP2012513764A (ja) * | 2008-12-30 | 2012-06-21 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | コンパニオンアニマルにおいて体重に関連する障害を処置および予防するための組成物および方法 |
JP2012513766A (ja) * | 2008-12-30 | 2012-06-21 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | コンパニオンアニマルにおける変性関節病、骨関節炎、軟骨損傷、および関連する障害を処置する、または予防する方法 |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020076470A1 (en) | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
US8592479B2 (en) | 2000-10-31 | 2013-11-26 | Hill's Pet Nutrition, Inc. | Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals |
US8377904B2 (en) * | 2004-02-09 | 2013-02-19 | Hill's Pet Nutrition, Inc. | Composition and method for use in cartilage affecting conditions |
US8252742B2 (en) * | 2004-12-30 | 2012-08-28 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
AU2005322887B2 (en) | 2004-12-30 | 2010-03-11 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
JP4903796B2 (ja) | 2005-08-17 | 2012-03-28 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 腎疾患の予防及び治療のための方法及び組成物 |
JP2009545308A (ja) * | 2006-08-09 | 2009-12-24 | ザ アイムス カンパニー | 骨の健康及び筋肉の健康を改善する方法 |
WO2008103958A1 (en) * | 2007-02-22 | 2008-08-28 | Hill's Pet Nutrition, Inc. | Compositions and methods for altering gene expression |
EP2155904A2 (en) | 2007-05-01 | 2010-02-24 | Hill's Pet Nutrition Inc. | Methods and compositions for diagnosing osteoarthritis in a feline |
CN105267969A (zh) | 2008-01-04 | 2016-01-27 | 雀巢产品技术援助有限公司 | 包含不饱和脂肪酸和一氧化氮释放化合物的组合物及其用于增强认知和相关功能的用途 |
BRPI0915974A2 (pt) * | 2008-07-18 | 2017-05-30 | Hill´S Pet Nutrition Inc | métodos para modular funções biológicas, para tratar um animal sofrendo de um distúrbio ou doença, para alterar a expressão de pelo menos um peptídeo em um mamífero, e para triar um ou mais compostos de teste para habilidade para alterar a expressão de pelo menos um gene de interesse em um mamífero |
AU2013200758B2 (en) * | 2008-07-18 | 2014-06-12 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
EP2334196B1 (en) * | 2008-09-11 | 2012-08-29 | The IAMS Company | Animal feed kibble with protein-based core and related methods |
AU2016200420B2 (en) * | 2008-12-30 | 2017-03-02 | Hill's Pet Nutrition, Inc. | Companion animal compositions including lipoic acid and methods of use thereof |
RU2564089C2 (ru) | 2010-05-12 | 2015-09-27 | Хилл`С Пет Ньютришн, Инк. | Способы диагностики, контроля и профилактики воспаления и смягчения воспалительных состояний у псовых |
AU2011253202B2 (en) * | 2010-05-12 | 2014-04-24 | Hill's Pet Nutrition, Inc. | Methods of control and prophylaxis of inflammation and mitigation of inflammatory conditions in companion animals |
US20130059028A1 (en) * | 2011-09-01 | 2013-03-07 | Julie Marie Foy | Compositions and Methods for Providing a Life-Stage-Appropriate Animal Diet |
CN103461665B (zh) * | 2013-09-23 | 2015-01-28 | 大连圣弘医药有限公司 | 一种适用于老年及术后恢复宠物的功能食品配方及其制备方法 |
CN103461666B (zh) * | 2013-09-23 | 2014-12-31 | 大连圣弘医药有限公司 | 一种具有调节胃肠功能的宠物功能食品配方及其制备方法 |
CA2926599C (en) * | 2013-11-05 | 2021-05-04 | Hill's Pet Nutrition, Inc. | Methods and compositions for improving kidney function |
CA2982836A1 (en) | 2015-04-28 | 2016-11-03 | Mars, Incorporated | Process of preparing a sterilized wet pet food product |
GB201522304D0 (en) | 2015-12-17 | 2016-02-03 | Mars Inc | Food product for reducing muscle breakdown |
GB201522300D0 (en) * | 2015-12-17 | 2016-02-03 | Mars Inc | Puppy growth food product |
CN106172061B (zh) * | 2016-08-31 | 2022-04-22 | 广西南宁灵康赛诺科生物科技有限公司 | 一种自动给食器 |
CA3029291C (en) | 2016-12-15 | 2024-06-04 | Rondo P. Middleton | Compositions and methods for small canines |
CN112369525A (zh) * | 2020-11-12 | 2021-02-19 | 上海比瑞吉宠物用品股份有限公司 | 适于老年犬的犬粮及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5519090A (en) * | 1978-07-25 | 1980-02-09 | Jerky Treats Inc | Pet food product and method |
JPS57132849A (en) * | 1981-02-12 | 1982-08-17 | Sanwa Kagaku Kenkyusho:Kk | Preparation of aseptic health feed |
JPH0838063A (ja) * | 1994-04-18 | 1996-02-13 | Iams Co:The | オメガ−6及びオメガ−3脂肪酸含有ペットフード製品及び炎症皮ふ反応を低減する方法 |
JP2003527124A (ja) * | 2000-03-22 | 2003-09-16 | ソシエテ デ プロデユイ ネツスル ソシエテ アノニム | 歯に有益なペットフードおよびその製造方法 |
WO2004024930A2 (en) * | 2002-09-13 | 2004-03-25 | Suntory Limited | Process for production of transesterified oils/fats or triglycerides |
JP2004141130A (ja) * | 2002-08-28 | 2004-05-20 | Mars Inc | 特定の犬種に専用のドッグフード |
Family Cites Families (134)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2980716A (en) * | 1954-06-11 | 1961-04-18 | Research Corp | Method for preparing 6, 8-dihalooctanoic esters |
US3202514A (en) * | 1963-07-15 | 1965-08-24 | Gen Foods Corp | Animal food and method of making the same |
US6090414A (en) * | 1970-05-20 | 2000-07-18 | Life Science Labs, Inc. | Method and composition to reduce cancer incidence |
US3946123A (en) * | 1975-03-10 | 1976-03-23 | Star-Kist Foods, Inc. | Canned pet food |
US4053647A (en) * | 1975-12-12 | 1977-10-11 | Samuel Prussin | Pet food product and process of producing such |
US4247562A (en) * | 1978-12-21 | 1981-01-27 | The Quaker Oats Company | Moist pet food with blood chunks and a fluid gravy system |
US5004624A (en) * | 1983-03-14 | 1991-04-02 | Star-Kist Foods, Inc. | Semi-moist pet food having free gravy and process for preparation thereof |
US4898890A (en) * | 1986-06-21 | 1990-02-06 | Dainippon Ink And Chemicals, Inc. | Medicines for use in the therapy and prevention of kidney and liver diseases |
US5030458A (en) * | 1989-11-27 | 1991-07-09 | Shug Austin L | Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats |
US4997672A (en) * | 1987-03-10 | 1991-03-05 | Virginia Commonwealth University | Salt taste enhancer |
EP0326034B1 (de) * | 1988-01-28 | 1992-08-26 | Peter Dr. Költringer | Kombinationspräparat zur Behandlung von Nervenzell-und Nervenfasererkrankungen und Verletzungen |
US6977167B2 (en) * | 1988-09-07 | 2005-12-20 | Martek Biosciences Corporation | Mixtures of omega-3 and omega-6 highly unsaturated fatty acids from euryhaline microorganisms |
US4997671A (en) * | 1988-09-09 | 1991-03-05 | Nabisco Brands, Inc. | Chewy dog snacks |
US5114704A (en) * | 1989-05-30 | 1992-05-19 | Nabisco Brands, Inc. | Raw hide having a coating containing an inorganic pyrophosphate |
US5200218A (en) * | 1989-11-08 | 1993-04-06 | Lasater Priscilla D | Composition for dog food |
DE4035442B4 (de) * | 1989-11-09 | 2010-04-29 | Evonik Degussa Gmbh | Arzneimittel enthaltend als Wirkstoff R-α-Liponsäure |
KR920007672B1 (ko) * | 1990-02-10 | 1992-09-14 | 한국식품개발연구원 | 오메가 지방산 함량이 높고 콜레스테롤 함량이 적은 고기를 생산하기 위한 지방사료첨가제의 제조방법 |
US6746678B1 (en) * | 1991-02-22 | 2004-06-08 | Howard K. Shapiro | Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments |
US5419283A (en) * | 1992-04-08 | 1995-05-30 | Ciuffo Gatto S.R.L. | Animal chew toy of starch material and degradable ethylene copolymer |
US5569670A (en) | 1992-06-05 | 1996-10-29 | Asta Medica Aktiengesellschaft | Combination medications containing alpha-lipoic acid and related |
US5624896A (en) * | 1992-06-09 | 1997-04-29 | Neorx Corporation | Clearing agents useful in pretargeting methods |
US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
DE4235912C2 (de) * | 1992-10-23 | 2002-12-05 | Viatris Gmbh | Verfahren zur Herstellung kristalliner Thioctsäure und deren Verwendung |
JP3347381B2 (ja) * | 1993-01-27 | 2002-11-20 | 協和醗酵工業株式会社 | ペットフード |
US5532010A (en) * | 1993-05-28 | 1996-07-02 | Nabisco, Inc. | Coated canine biscuits and preparation process |
US5339771A (en) * | 1993-09-15 | 1994-08-23 | Axelrod Herbert R | Animal chew toy containing animal meal |
EP0732933B1 (en) * | 1993-11-15 | 2002-10-09 | Celtrix Pharmaceuticals, Inc. | Use of igf-1 and igfbp-3 in the manufacture of a medicament for treating a renal disorder |
US7105607B2 (en) | 1994-04-19 | 2006-09-12 | Applied Elastomerics, Inc. | Tear resistant gels, composites, and articles |
US6458767B1 (en) | 1994-05-04 | 2002-10-01 | The Uab Research Foundation | Use of peptides inhibitory for thrombospondin dependent TGF-β activation in the treatment of kidney disease |
DE4427079C2 (de) * | 1994-07-30 | 2002-12-19 | Viatris Gmbh | Verfahren zur Racemisierung von Enantiomeren der alpha-Liponsäure |
US5976548A (en) | 1994-11-08 | 1999-11-02 | Viva America Marketing, Inc. | Nutritional supplement composition and use |
US5599835A (en) * | 1994-11-23 | 1997-02-04 | Fischer; Frederick B. | Use of DL-lipoic acid as a medical food in the treatment of diabetes mellitus |
US5730988A (en) * | 1995-04-20 | 1998-03-24 | Lynntech, Inc. | Nutritional supplements for improving glucose metabolism |
US6184227B1 (en) * | 1995-07-21 | 2001-02-06 | Savvipharm Inc. | Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
FR2738741B1 (fr) * | 1995-09-19 | 1997-12-05 | Oreal | Composition pour la teinture des fibres keratiniques, contenant un antagoniste de substance p |
US5776913A (en) * | 1995-10-10 | 1998-07-07 | Colgate Palmolive Company | Therapeutic diet for metabolic abnormalities found in animals with lymphoma |
CA2208392C (en) * | 1996-06-21 | 2002-09-03 | University Of Guelph | Method for enriching docosahexaenoic acid in expressed milk of dairy cattle |
US5977162A (en) | 1996-09-16 | 1999-11-02 | Seidman; Michael D. | Therapeutic treatment for auditory function |
AU744156B2 (en) * | 1996-10-28 | 2002-02-14 | General Mills Inc. | Embedding and encapsulation of controlled release particles |
US5976568A (en) | 1997-02-21 | 1999-11-02 | Medical Doctors' Research Institute, Inc. | Modular system of dietary supplement compositions for optimizing health benefits and methods |
US6232346B1 (en) * | 1997-03-27 | 2001-05-15 | Michael J. Sole | Composition for improvement of cellular nutrition and mitochondrial energetics |
US6080788A (en) * | 1997-03-27 | 2000-06-27 | Sole; Michael J. | Composition for improvement of cellular nutrition and mitochondrial energetics |
US6133323A (en) | 1997-04-09 | 2000-10-17 | The Iams Company | Process for enhancing immune response in animals using β-carotene as a dietary supplement |
US5851573A (en) | 1997-04-29 | 1998-12-22 | The Iams Company | Pet food composition for large breed puppies and method for promoting proper skeletal growth |
US6264994B1 (en) * | 1997-05-15 | 2001-07-24 | University Of Washington | Compositions for treating alzheimer's disease and other amyloidoses |
US5883083A (en) * | 1997-06-09 | 1999-03-16 | Harlmen, Inc. | Dietary supplement for alleviating behavioral problems in canines and reducing seizures in canines and felines |
US5916912A (en) * | 1997-06-16 | 1999-06-29 | The Regents Of The University Of California | Dietary composition for enhancing metabolism and alleviating oxidative stress |
DE19726519A1 (de) | 1997-06-23 | 1998-12-24 | Asta Medica Ag | Verfahren zur Herstellung trockener Thioctsäure |
EP0891719A1 (en) * | 1997-07-14 | 1999-01-20 | N.V. Nutricia | Nutritional composition containing methionine |
US6039952A (en) | 1997-10-22 | 2000-03-21 | The Iams Company | Composition and method for improving clinical signs in animals with renal disease |
GB9722361D0 (en) | 1997-10-24 | 1997-12-17 | Pharma Nord Uk Ltd | Pharmaceutical formulation for treating liver disorders |
US6365623B1 (en) * | 1997-11-17 | 2002-04-02 | Nicholas V. Perricone | Treatment of acne using lipoic acid |
DE19810336A1 (de) | 1998-03-11 | 1999-09-23 | Asta Medica Ag | Alpha-Liponsäure mit neuartiger Modifikation |
US6117477A (en) * | 1998-03-18 | 2000-09-12 | Kal Kan Foods, Inc. | Multicomponent food product and methods of making and using the same |
RU2131677C1 (ru) | 1998-05-05 | 1999-06-20 | Научно-производственная фирма "Аквазинэль" | Кормовая добавка "биовитос" |
US6492325B1 (en) | 1998-05-22 | 2002-12-10 | Boys Town National Research Hospital | Use of α1β1 integrin receptor inhibitors and TGF-β1 inhibitors in the treatment of kidney disease |
US6197340B1 (en) * | 1998-05-28 | 2001-03-06 | Medical Research Institute | Controlled release lipoic acid |
DE19834608A1 (de) * | 1998-07-31 | 2000-02-03 | Basf Ag | Kristallmodifikation der Liponsäure |
US6136339A (en) | 1998-08-21 | 2000-10-24 | Gardiner; Paul T. | Food supplements and methods comprising lipoic acid and creatine |
IT1302307B1 (it) * | 1998-09-01 | 2000-09-05 | Sigma Tau Healthscience Spa | Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil |
US6245379B1 (en) * | 1998-09-30 | 2001-06-12 | The Iams Company | Method of administering a milk substitute to critical care animals |
FR2786100B1 (fr) | 1998-11-24 | 2002-03-01 | Aventis Laboratoire | Nouvelle application therapeutique de la nicergoline |
AUPP784398A0 (en) * | 1998-12-21 | 1999-01-21 | Monash University | Kidney disease detection and treatment |
US20040029175A1 (en) * | 1998-12-21 | 2004-02-12 | Comper Wayne D. | Method for kidney disease detection |
ATE376187T1 (de) * | 1998-12-21 | 2007-11-15 | Univ Monash | Nachweis von erkrankungen der nieren und behandlung |
US6284786B1 (en) * | 1999-02-16 | 2001-09-04 | The Center For The Improvement Of Human Functioning, Int'l., Inc. | Treatment of cancer using lipoic acid in combination with ascorbic acid |
AUPP887399A0 (en) * | 1999-02-24 | 1999-03-25 | Bartlett Grain Pty Ltd | Animal feed formulae for the nutritional enrichment of foodstuffs |
PT1033364E (pt) * | 1999-03-01 | 2005-07-29 | Pfizer Prod Inc | Ciano com acidos oxamicos e derivados como ligandos de receptores de tiroide |
IT1306130B1 (it) | 1999-04-16 | 2001-05-30 | Sigma Tau Healthscience Spa | Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti. |
ATE301937T1 (de) | 1999-05-27 | 2005-09-15 | Iams Company | Verfahren zur herstellung eines produkts zur erhöhung der immunantwort bei haustieren mit verwendung einer kombination von antioxidantien |
US6365211B1 (en) * | 1999-06-18 | 2002-04-02 | The Procter & Gamble Co. | Cooking aid with reduced foaming |
US6479069B1 (en) | 1999-09-23 | 2002-11-12 | Juvenon, Inc. | Nutritional supplement for increased energy and stamina |
US6426362B1 (en) * | 1999-10-08 | 2002-07-30 | Galileo Laboratories, Inc. | Formulations of tocopherols and methods of making and using them |
IL149421A0 (en) * | 1999-11-02 | 2002-11-10 | Depomed Inc | Pharmaceutical compositions containing fed mode inducing agents |
US6335361B1 (en) * | 1999-11-03 | 2002-01-01 | Juvenon Inc. | Method of treating benign forgetfulness |
US6379727B1 (en) * | 1999-12-29 | 2002-04-30 | John F. Addy | Flavoring system for pet foods |
US20030060503A1 (en) * | 2000-01-25 | 2003-03-27 | Juvenon, Inc. | Nutritional supplements for mature pets |
WO2001058271A1 (en) | 2000-01-25 | 2001-08-16 | Juvenon, Inc. | Nutritional supplements for aged pets |
CZ20022927A3 (cs) * | 2000-02-01 | 2003-06-18 | Muscletech Research And Development Inc. | Doplňky stravy založené na alfa-lipoové kyselině pro zvýšení čisté svalové hmoty a síly |
JP4487376B2 (ja) * | 2000-03-31 | 2010-06-23 | 味の素株式会社 | 腎疾患治療剤 |
EP1155627A1 (en) | 2000-05-18 | 2001-11-21 | Belovo Eggs & Egg Products | Eggs with balanced lipid composition |
MXPA03001240A (es) * | 2000-08-10 | 2004-09-10 | Renessen Llc | Productos que comprenden aceite de maiz y harina de maiz obtenidos a partir de maiz alto en aceite. |
US20020044988A1 (en) * | 2000-08-22 | 2002-04-18 | Fuchs Eileen C. | Nutritional composition and method for improving protein deposition |
AU2001292586A1 (en) * | 2000-09-07 | 2002-03-22 | University Of Maryland Biotechnology Institute | Use of arachidonic acid for enhanced culturing of fish larvae and broodstock |
US6784159B2 (en) * | 2000-09-29 | 2004-08-31 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture | Triterpene saponins from soybeans for treating kidney disease |
US6277842B1 (en) * | 2000-10-17 | 2001-08-21 | James Alexander Carthron | Dietary supplemental method for fat and weight reduction |
US20020076469A1 (en) * | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
US20020052402A1 (en) * | 2000-10-31 | 2002-05-02 | Colgate-Palmolive Company | Composition and method |
US8669282B2 (en) * | 2000-10-31 | 2014-03-11 | Hill's Pet Nutrition, Inc. | Companion animal compositions including lipoic acid and methods of use thereof |
US20020076470A1 (en) | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
US20020115710A1 (en) * | 2000-10-31 | 2002-08-22 | Zicker Steven Curtis | Composition and method |
US8592479B2 (en) * | 2000-10-31 | 2013-11-26 | Hill's Pet Nutrition, Inc. | Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals |
US20090156658A1 (en) * | 2000-10-31 | 2009-06-18 | Hill's Pet Nutrition, Inc. | Antioxidant-Containing Food Composition For Use In Inhibiting Histamine Pathways In Companion Animals |
US6517877B2 (en) * | 2000-12-29 | 2003-02-11 | Martin Francis Gannon | Animal food product |
EP1372412A2 (en) * | 2001-03-09 | 2004-01-02 | Societe Des Produits Nestle S.A. | Composition improving age-related physiological deficits and increasing longevity |
US7001610B2 (en) | 2001-04-23 | 2006-02-21 | Omeganutrel Inc. | Food supplement and use thereof for elevating levels of essential fatty acids in livestock and products therefrom |
ATE549938T1 (de) * | 2001-05-14 | 2012-04-15 | Martek Biosciences Corp | Verfahren zur verbesserung des geschmacks, der zartheit und der verbraucherakzeptanz insgesamt von geflügelfleisch |
US6596762B2 (en) * | 2001-05-17 | 2003-07-22 | The Regents Of The University Of Colorado | Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis |
US6596768B2 (en) * | 2001-05-22 | 2003-07-22 | Church & Dwight Co., Inc. | Unsaturated lipid-enriched feedstock for ruminants |
US6902739B2 (en) * | 2001-07-23 | 2005-06-07 | Nutracea | Methods for treating joint inflammation, pain, and loss of mobility |
GB0119052D0 (en) * | 2001-08-03 | 2001-09-26 | Mars Uk Ltd | Foodstuff |
US6923960B2 (en) * | 2001-10-03 | 2005-08-02 | Vsl Pharmaceuticals Inc. | Antioxidant combination composition and use thereof |
GB0129864D0 (en) * | 2001-12-13 | 2002-02-06 | Danisco | Animal feed |
US20030190343A1 (en) * | 2002-03-05 | 2003-10-09 | Pfizer Inc. | Palatable pharmaceutical compositions for companion animals |
EP1350435B1 (en) | 2002-04-05 | 2010-12-22 | Societe Des Produits Nestle S.A. | Compositions and methods for promoting lipid assimilation in pets |
US20030194478A1 (en) * | 2002-04-12 | 2003-10-16 | Davenport Gary Mitchell | Dietary methods for canine performance enhancement |
US6733793B2 (en) | 2002-06-04 | 2004-05-11 | Metaproteomics, Llc | Oral composition with insulin-like activities and methods of use |
US6572899B1 (en) * | 2002-07-03 | 2003-06-03 | Vitacost.Com, Inc. | Memory loss treatment formulation |
EP1544281B1 (en) * | 2002-08-07 | 2016-10-05 | Kao Corporation | Fat composition |
US20060083796A1 (en) * | 2002-09-09 | 2006-04-20 | Sylvie Pridmore-Merten | Orally administrable composition for improving hair and coat quality |
US6974841B1 (en) | 2002-09-27 | 2005-12-13 | Rapisarda Family Irrevocable Trust | Pet anti-aging wellness supplement |
RU2221456C1 (ru) | 2003-03-11 | 2004-01-20 | Общество с ограниченной ответственностью "Арсентех" | Биологически активное вещество, биологически активная добавка к пище, фармацевтический препарат, биологически активная добавка для кормления животных, ветеринарный препарат, удобрение, активатор микробиологических процессов, пероральное питание, парфюмерно-косметическое средство, гигиеническое средство, молочный продукт, кондитерское изделие, хлебобулочное изделие, масло-жировой продукт, соус, алкогольный напиток, безалкогольный напиток, рыбный продукт, мясной продукт, макаронные изделия, жевательная резинка, пиво |
US20080057039A1 (en) * | 2003-05-13 | 2008-03-06 | Martha Karen Newell Rogers | Diagnostic and Therapeutic Treatments Related to Mitochondrial Disorders |
US7202270B2 (en) * | 2003-06-20 | 2007-04-10 | Sami Labs Limited | Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses |
DE602004032579D1 (de) * | 2003-11-25 | 2011-06-16 | Virginia Tech Intell Prop | Zusammensetzung für den tierischen verzehr sowie verfahren zur reduktion der map-kinaseaktivität |
US7078064B2 (en) * | 2003-12-03 | 2006-07-18 | George Zabrecky | Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis |
JP2007532121A (ja) | 2004-04-16 | 2007-11-15 | ネステク ソシエテ アノニム | 動物における酸化ストレスを低減する方法および組成物 |
US20050266051A1 (en) | 2004-05-27 | 2005-12-01 | The Procter & Gamble Company | Pet food compositions and methods |
US20060002985A1 (en) * | 2004-07-02 | 2006-01-05 | Zicker Steven C | Compositions and methods for decreasing age-related deterioration in mental activities in companion animals |
RU2433819C2 (ru) * | 2004-11-09 | 2011-11-20 | Хилл'С Пет Ньютришн, Инк. | Применение антиоксидантов для модуляции генов |
WO2006058248A2 (en) | 2004-11-24 | 2006-06-01 | Hill's Pet Nutrition, Inc. | Methods for increasing the immune response in an animal |
RU2432159C2 (ru) * | 2004-11-24 | 2011-10-27 | Хилл'С Пет Ньютришн, Инк. | Способы для улучшения обезвреживания печенью ксенобиотических веществ у животных |
US20090176864A1 (en) * | 2004-11-24 | 2009-07-09 | Hill's Pet Nutrition, Inc. | Methods For Improving Hepatic and Immune Function In An Animal |
US8168161B2 (en) * | 2004-12-22 | 2012-05-01 | Hill's Pet Nutrition, Inc. | Method to promote oral health in companion animals |
WO2006071919A2 (en) * | 2004-12-29 | 2006-07-06 | Hill's Pet Nutrition, Inc. | Methods for inhibiting a decline in learning and/or memory in animals |
US8647660B2 (en) * | 2004-12-29 | 2014-02-11 | Hill's Pet Nutrition, Inc. | Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health |
AU2005322887B2 (en) | 2004-12-30 | 2010-03-11 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
US8252742B2 (en) * | 2004-12-30 | 2012-08-28 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
CN101262780B (zh) * | 2005-07-14 | 2013-04-24 | 希尔氏宠物营养品公司 | 一种延长动物生命的方法 |
JP4903796B2 (ja) * | 2005-08-17 | 2012-03-28 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 腎疾患の予防及び治療のための方法及び組成物 |
US7282225B1 (en) | 2006-09-27 | 2007-10-16 | Occular Technologies, Inc. | Composition and methods for improving retinal health |
US20080299286A1 (en) | 2007-06-04 | 2008-12-04 | David B Josephson | Palatability enhancing compositions and foods for pets, and methods regarding the same |
CA2691691C (en) | 2007-06-20 | 2013-09-24 | Seth J. Baum | Compositions and methods of treating chronic kidney disease |
US20080317884A1 (en) | 2007-06-22 | 2008-12-25 | Jewell Dennis E | Enhancing Disease Resistance In An Animal |
-
2005
- 2005-12-30 AU AU2005322887A patent/AU2005322887B2/en not_active Ceased
- 2005-12-30 US US11/813,276 patent/US8148325B2/en active Active
- 2005-12-30 EP EP05855950A patent/EP1830629A4/en not_active Withdrawn
- 2005-12-30 CA CA2592844A patent/CA2592844C/en not_active Expired - Fee Related
- 2005-12-30 CN CN2005800487331A patent/CN101128109B/zh not_active Expired - Fee Related
- 2005-12-30 JP JP2007549655A patent/JP5295567B2/ja active Active
- 2005-12-30 CN CN2012104181100A patent/CN102907561A/zh active Pending
- 2005-12-30 RU RU2007128930/12A patent/RU2367195C2/ru not_active IP Right Cessation
- 2005-12-30 CA CA2784197A patent/CA2784197C/en not_active Expired - Fee Related
- 2005-12-30 WO PCT/US2005/047461 patent/WO2006074089A2/en active Application Filing
- 2005-12-30 BR BRPI0519610-8A patent/BRPI0519610A2/pt not_active IP Right Cessation
-
2007
- 2007-06-29 ZA ZA2007/05214A patent/ZA200705214B/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5519090A (en) * | 1978-07-25 | 1980-02-09 | Jerky Treats Inc | Pet food product and method |
JPS57132849A (en) * | 1981-02-12 | 1982-08-17 | Sanwa Kagaku Kenkyusho:Kk | Preparation of aseptic health feed |
JPH0838063A (ja) * | 1994-04-18 | 1996-02-13 | Iams Co:The | オメガ−6及びオメガ−3脂肪酸含有ペットフード製品及び炎症皮ふ反応を低減する方法 |
JP2003527124A (ja) * | 2000-03-22 | 2003-09-16 | ソシエテ デ プロデユイ ネツスル ソシエテ アノニム | 歯に有益なペットフードおよびその製造方法 |
JP2004141130A (ja) * | 2002-08-28 | 2004-05-20 | Mars Inc | 特定の犬種に専用のドッグフード |
WO2004024930A2 (en) * | 2002-09-13 | 2004-03-25 | Suntory Limited | Process for production of transesterified oils/fats or triglycerides |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011505876A (ja) * | 2007-12-21 | 2011-03-03 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | ペット用飼料組成物 |
JP2012513767A (ja) * | 2008-12-30 | 2012-06-21 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | リポ酸を含むコンパニオンアニマル用組成物およびその使用の方法 |
JP2012513764A (ja) * | 2008-12-30 | 2012-06-21 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | コンパニオンアニマルにおいて体重に関連する障害を処置および予防するための組成物および方法 |
JP2012513766A (ja) * | 2008-12-30 | 2012-06-21 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | コンパニオンアニマルにおける変性関節病、骨関節炎、軟骨損傷、および関連する障害を処置する、または予防する方法 |
JP2015109850A (ja) * | 2008-12-30 | 2015-06-18 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | コンパニオンアニマルにおける変性関節病、骨関節炎、軟骨損傷、および関連する障害を処置する、または予防する方法 |
JP2015119710A (ja) * | 2008-12-30 | 2015-07-02 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | リポ酸を含むコンパニオンアニマル用組成物およびその使用の方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101128109B (zh) | 2013-07-03 |
CN101128109A (zh) | 2008-02-20 |
AU2005322887B2 (en) | 2010-03-11 |
CA2784197A1 (en) | 2006-07-13 |
EP1830629A2 (en) | 2007-09-12 |
BRPI0519610A2 (pt) | 2009-02-25 |
AU2005322887A1 (en) | 2006-07-13 |
CA2592844C (en) | 2012-10-09 |
CN102907561A (zh) | 2013-02-06 |
WO2006074089A3 (en) | 2007-07-05 |
US8148325B2 (en) | 2012-04-03 |
CA2592844A1 (en) | 2006-07-13 |
JP5295567B2 (ja) | 2013-09-18 |
US20080206398A1 (en) | 2008-08-28 |
CA2784197C (en) | 2015-09-01 |
RU2367195C2 (ru) | 2009-09-20 |
EP1830629A4 (en) | 2008-08-27 |
ZA200705214B (en) | 2015-12-23 |
WO2006074089A2 (en) | 2006-07-13 |
RU2007128930A (ru) | 2009-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5295567B2 (ja) | 高齢期の動物の生活の質を高めるための方法 | |
AU2010201222B2 (en) | Methods for enhancing the quality of life of a growing animal | |
CA2636292C (en) | Methods for reducing food intake and controlling the weight of animals | |
ZA200604459B (en) | Palatability enhanced composition and method for animal consumption | |
CN1905807A (zh) | 用于动物消费的组合物和降低map激酶活性的方法 | |
RU2727434C1 (ru) | Кормовые композиции для домашних животных и способы их получения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20081119 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110719 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20110912 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111019 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20121003 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130204 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20130321 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130530 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130612 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5295567 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |